Shiga toxin-binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms

Molecular Biology of the Cell

Volumn 24, Issue 15, 2013, Pages 2311-2318

  Mukhopadhyay, Somshuvra ^a,b   Redler, Brendan ^a   Linstedt, Adam D ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; BACTERIAL TOXIN; CELL RECEPTOR; GPP130 PROTEIN; HISTIDINE; MANGANESE; MEMBRANE PROTEIN; SHIGA TOXIN; SHIGA TOXIN B SUBUNIT; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2;

ARTICLE; BINDING SITE; CELL MIGRATION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; MOLECULAR EVOLUTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; SHIGELLA;

EID: 84881044294     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-01-0057     Document Type: Article

References (33)

1. Aschner M, Erikson KM, Herrero Hernandez E, Tjalkens R (2009). Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromol Med 11, 252-266.
2. Bachert C, Lee TH, Linstedt AD (2001). Lumenal endosomal and Golgi-retrieval determinants involved in pH-sensitive targeting of an early Golgi protein. Mol Biol Cell 12, 3152-3160.
3. Beddoe T, Paton AW, Le Nours J, Rossjohn J, Paton JC (2010). Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci 35, 411-418.
4. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL (1999). Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37, 497-503.
5. Bretscher MS, Munro S (1993). Cholesterol and the Golgi apparatus. Science 261, 1280-1281.
6. Burk C, Dietrich R, Acar G, Moravek M, Bulte M, Martlbauer E (2003). Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin. J Clin Microbiol 41, 2106-2112.
7. Chinnapen DJ et al. (2012). Lipid sorting by ceramide structure from plasma membrane to ER for the cholera toxin receptor ganglioside GM1. Dev Cell 23, 573-586.
8. Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, Salamero J, Johannes L (2001). Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12, 2453-2468.
9. Fontaine A, Arondel J, Sansonetti PJ (1988). Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox-mutant of Shigella dysenteriae 1. Infect Immun 56, 3099-3109.
10. Gannon VP, Teerling C, Masri SA, Gyles CL (1990). Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. J Gen Microbiol 136, 1125-1135.
11. Johannes L, Popoff V (2008). Tracing the retrograde route in protein trafficking. Cell 135, 1175-1187.
12. Johannes L, Wunder C (2011). Retrograde transport: two (or more) roads diverged in an endosomal tree. Traffic 12, 956-962.
13. Keusch GT, Jacewicz M (1977). The pathogenesis of Shigella diarrhea. VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans. J Infect Dis 135, 552-556.
14. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM (1999). Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Org 77, 651-666.
15. Ling H, Boodhoo A, Hazes B, Cummings MD, Armstrong GD, Brunton JL, Read RJ (1998). Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37, 1777-1788.
16. Linstedt AD, Mehta A, Suhan J, Reggio H, Hauri HP (1997). Sequence and overexpression of GPP130/GIMPc: evidence for saturable pH-sensitive targeting of a type II early Golgi membrane protein. Mol Biol Cell 8, 1073-1087.
17. Mallard F, Antony C, Tenza D, Salamero J, Goud B, Johannes L (1998). Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of Shiga toxin B-fragment transport. J Cell Biol 143, 973-990.
18. Mohawk KL, O'Brien AD (2011). Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection. J Biomed Biotechnol 2011, 258185.
19. Mukhopadhyay S, Bachert C, Smith DR, Linstedt AD (2010). Manganese-induced trafficking and turnover of the cis-Golgi glycoprotein GPP130. Mol Biol Cell 21, 1282-1292.
20. Mukhopadhyay S, Linstedt AD (2011). Identification of a gain-of-function mutation in a Golgi P-type ATPase that enhances Mn2+ efflux and protects against toxicity. Proc Natl Acad Sci USA 108, 858-863.
21. Mukhopadhyay S, Linstedt AD (2012). Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335, 332-335.
22. Nataro JP, Pickering LK (2006). Oski's Paediatrics: Principles and Practice, Philadelphia: Lippincott Williams & Wilkins.
23. O'Brien AD, Holmes RK (1987). Shiga and Shiga-like toxins. Microbiol Rev 51, 206-220.
24. O'Brien AD, Thompson MR, Gemski P, Doctor BP, Formal SB (1977). Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun 15, 796-798.
25. Pieper U et al. (2006). MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res 34, D291-D295.
26. Reller ME, Griffin PM (2004). Infectious Diseases, Philadelphia: Lippincott Williams & Wilkins.
27. Schmitt CK, McKee ML, O'Brien AD (1991). Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H-strain E32511. Infect Immun 59, 1065-1073.
28. Shin IS, Ishii S, Shin JS, Sung KI, Park BS, Jang HY, Kim BW (2009). Globotriaosylceramide (Gb3) content in He La cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression. BMB Rep 42, 310-314.
29. Strockbine NA, Jackson MP, Sung LM, Holmes RK, O'Brien AD (1988). Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol 170, 1116-1122.
30. Tam P, Mahfoud R, Nutikka A, Khine AA, Binnington B, Paroutis P, Lingwood C (2008). Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J Cell Physiol 216, 750-763.
31. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, O'Brien AD, Samuel JE (1993). Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61, 3392-3402.
32. Weinstein DL, Jackson MP, Samuel JE, Holmes RK, O'Brien AD (1988). Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J Bacteriol 170, 4223-4230.
33. Zhang W, Bielaszewska M, Friedrich AW, Kuczius T, Karch H (2005). Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. Appl Environ Microbiol 71, 558-561.